Airway ShieldTM

The world’s first device that facilitates endotracheal intubation while protecting the patient and the clinician

Disruptive concept, smart design, revolutionary technology

Endotracheal Intubation

A Critical Life-Saving Procedure

+100

Million

Intubations Per Year

The 3rd most performed medical procedure in all hospitals worldwide.  It allows mechanical ventilation, which enables anaesthesia for surgery and emergency treatment of critically ill patients.

1/3

of the medico-legal complaints related to Anesthesia are due to Dental Trauma

Dental injury is the most common complication of laryngoscopy. Trauma to patient’s oral mucosa and teeth during intubation is a minor but frequent problem.

45%

of Intubations in critically ill patients end in Severe Complications

Hypoxaemia, haemodynamic instability, cardiac arrest, and even death make ETI a high-risk procedure for patients. Furthermore, 12% of emergency intubations fail.

10%

of clinicians got Infected when involved in the intubation of a COVID19 patient

In addition, ETI is a highly skilled technique, performed not only in operating theatres by anaesthetists, but also in intensive care and emergency departments, and in pre-hospital settings by less trained staff.

The Airway ShieldTM

Making ETI easier, faster and safer

Home - Ronda Dic 2023
The sealed “Central Opening” allows the laryngoscope blade and endotracheal tube to pass through, while minimizing the spread of aerosols and droplets.
The ‘Shield’ covers the patient’s mouth and protects the operator from the risk of infection.
The sealed “Lateral Openings” allow the aspiration of secretions and/or aerosols.
The “Guiding-Channel” facilitates intubation by directing the endotracheal tube into the trachea. Its “Reinforced Area” also protects the teeth during intubation.
Home (ene 2025)

How it works

The Airway ShieldTM stabilizes the airway, keeping the mouth open, and guides the endotracheal tube (ETT), which easily follows the direction set by the laryngoscope blade towards the vocal cords

The benefits

The Airway ShieldTM increases intubation success and reduces associated complications

Patient protection

Protects patient’s teeth and mucosa, the most frequent intubation-related injuries.

Guided intubation

Reducing intubation time by almost 50% 1.

Clinician protection

Protects clinicians from infection by decreasing the spread of aerosols and droplets by up to 95% 2.

Easy to use

Minimal training required.

 Portable

Available and ready to use in any circumstance.

Low-cost

Simple solution to a complex problem.

Disruptive technology

Revolutionary yet simple design.

Patented

Design and method protected by an international patent.

Testimonials

What the experts have to say about our device

Simple, intuitive and easy to use. This device facilitates intubation and provides safety to the professional against the generation of aerosols.

Ana MendigurenAnaesthesiologist, University Hospital Araba

A barrier that can be crucial in the professional protection.

Mikel BibankoAnaesthesiologist, University Hospital Araba

A breakthrough in the field of security combined with easy to use technology, even for those with little experience.

Jon RenteriaSecond-Year Resident in Anaesthesiology, University Hospital Araba

Device easy to use, comfortable to place and facilitates ventilation and intubation, using laryngoscope as well as videolaryngoscope. And at the same time protects you against aerosols.

Fidel de CelisAnaesthesiologist, University Hospital Araba

Meet the team

Home (ene 2025)
Founder and CEO

Dr. Julio Alonso

Dr. Julio Alonso is the clinical expert of the team and the inventor of the Airway Shield device. He is an Intensive Care specialist who identified the clinical need, thus initiating the Airway Shield project. He leads the team and is responsible of medical coordination and overall business strategy of the company.
Home (ene 2025)
Clinical Research & Medical Communication

Natalia Moracho

Natalia, PhD in Pharmacy and specialized in Clinical Research, is the responsible of scientific research, medical writing and communication, coordination of the validation studies and liaising with Key Opinion Leaders.
Home (ene 2025)
Quality and Distribution

Carlota Muñoz

Carlota Muñoz, master's degree in the Pharmaceutical Industry, specialized in Quality Control and Regulatory Affairs. She collaborates in tasks to ensure compliance with industry standards, guarantees all products meet legal and regulatory requirements, and stays updated on the latest regulations and guidelines.
Home (ene 2025)
Business Development Director

Joanne Zuo

Joanne Zuo is specialised in technology transition and commercialization. She is responsible for go-to-market strategy and global commercialization collaborations.
Home (ene 2025)
Business Management

Nieves Espinosa

Nieves Espinosa has a strong background in corporate journalism, and thus she is specialised in communication strategy with hospitals and KOLs.

Timeline

IDEA

International Patent Filed (PCT)
NEOTEC (CDTI non dilutive funding)
Japanese Patent Granted
PERTE (CDTI non dilutive funding)
1st Clinical Trial (Pilot)
CE Mark
2nd Clinical Trial (RCT)
2nd (progress) discussion with FDA
US Patent Granted
ANVISA (Brazil) and TITCK (Turkey) Registrations
Chinese and European Patent expected to be granted

COMMERCIAL LAUNCH

Partnerships

Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)
Home (ene 2025)

Awards

Get in touch

Calle Moctezuma 3, 1B
39003 Santander, Cantabria, Spain

Calle Cifuentes 5
28021 Madrid, Spain

Newsletter

Subscribe to our product newsletter for insights about our progress and airway management issues